Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes

scientific article published in May 2003

Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JGM.359
P698PubMed publication ID12731091

P2093author name stringGérald J Prud'homme
France Croze
P2860cites workSustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potencyQ42177647
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogueQ45872828
P433issue5
P921main subjectgene therapyQ213901
P304page(s)425-437
P577publication date2003-05-01
P1433published inJournal of Gene MedicineQ15746377
P1476titleGene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes
P478volume5

Reverse relations

cites work (P2860)
Q36226771Electric pulse-mediated gene delivery to various animal tissues
Q35906093Gene therapy for autoimmune diseases: quo vadis?
Q45875420Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes
Q90259907Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice
Q45867114In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes
Q36704473Plasmid-based gene therapy of diabetes mellitus
Q47993958Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA).
Q37994917Restoring insulin production for type 1 diabetes.

Search more.